These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7906851)

  • 1. Co-expression of dopamine transporter mRNA and tyrosine hydroxylase mRNA in ventral mesencephalic neurones.
    Augood SJ; Westmore K; McKenna PJ; Emson PC
    Brain Res Mol Brain Res; 1993 Dec; 20(4):328-34. PubMed ID: 7906851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: potential contributors to spontaneous recovery from experimental Parkinsonism.
    Rothblat DS; Schroeder JA; Schneider JS
    J Neurosci Res; 2001 Aug; 65(3):254-66. PubMed ID: 11494360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon.
    Blanchard V; Raisman-Vozari R; Vyas S; Michel PP; Javoy-Agid F; Uhl G; Agid Y
    Brain Res Mol Brain Res; 1994 Mar; 22(1-4):29-38. PubMed ID: 7912404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin induces tyrosine hydroxylase mRNA expression in the ventral mesencephalon but not in the hypothalamus.
    Venero JL; Absi el-H; Cano J; Machado A
    J Pineal Res; 2002 Jan; 32(1):6-14. PubMed ID: 11841594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced gene expression for dopamine biosynthesis and transport in midbrain neurons of adult male rats exposed prenatally to ethanol.
    Szot P; White SS; Veith RC; Rasmussen DD
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1643-9. PubMed ID: 10549997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: a molecular study.
    Figlewicz DP; Brot MD; McCall AL; Szot P
    Brain Res; 1996 Oct; 736(1-2):54-60. PubMed ID: 8930308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs.
    Seroogy KB; Lundgren KH; Tran TM; Guthrie KM; Isackson PJ; Gall CM
    J Comp Neurol; 1994 Apr; 342(3):321-34. PubMed ID: 7912699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the weaver mutation on the expression of dopamine membrane transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental area.
    Adelbrecht C; Agid Y; Raisman-Vozari R
    Brain Res Mol Brain Res; 1996 Dec; 43(1-2):291-300. PubMed ID: 9037545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity.
    Haber SN; Ryoo H; Cox C; Lu W
    J Comp Neurol; 1995 Nov; 362(3):400-10. PubMed ID: 8576447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion.
    Dal Bo G; Bérubé-Carrière N; Mendez JA; Leo D; Riad M; Descarries L; Lévesque D; Trudeau LE
    Neuroscience; 2008 Sep; 156(1):59-70. PubMed ID: 18706980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine transporter mRNA: dense expression in ventral midbrain neurons.
    Shimada S; Kitayama S; Walther D; Uhl G
    Brain Res Mol Brain Res; 1992 May; 13(4):359-62. PubMed ID: 1352613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ontogeny of dopamine transporter mRNA expression in the rat brain.
    Fujita M; Shimada S; Nishimura T; Uhl GR; Tohyama M
    Brain Res Mol Brain Res; 1993 Aug; 19(3):222-6. PubMed ID: 8412565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subpopulations of mesencephalic dopaminergic neurons express different levels of tyrosine hydroxylase messenger RNA.
    Weiss-Wunder LT; Chesselet MF
    J Comp Neurol; 1991 Jan; 303(3):478-88. PubMed ID: 1672536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal ontogeny of D2 dopamine receptor and dopamine transporter gene expression in the rat mesencephalon.
    Tison F; Normand E; Bloch B
    Neurosci Lett; 1994 Jan; 166(1):48-50. PubMed ID: 7910679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia.
    Galter D; Buervenich S; Carmine A; Anvret M; Olson L
    Neurobiol Dis; 2003 Dec; 14(3):637-47. PubMed ID: 14678778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter.
    Jaber M; Dumartin B; Sagné C; Haycock JW; Roubert C; Giros B; Bloch B; Caron MG
    Eur J Neurosci; 1999 Oct; 11(10):3499-511. PubMed ID: 10564358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinatal delta9-tetrahydrocannabinol exposure did not alter dopamine transporter and tyrosine hydroxylase mRNA levels in midbrain dopaminergic neurons of adult male and female rats.
    García-Gil L; Ramos JA; Rubino T; Parolaro D; Fernández-Ruiz JJ
    Neurotoxicol Teratol; 1998; 20(5):549-53. PubMed ID: 9761594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-type-specific expression of catecholamine transporters in the rat brain.
    Lorang D; Amara SG; Simerly RB
    J Neurosci; 1994 Aug; 14(8):4903-14. PubMed ID: 8046459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic mRNA expression in the intact substantia nigra of unilaterally 6-OHDA-lesioned and grafted rats: an in situ hybridization study.
    Drandarevski N; Marburger A; Walther D; Reum T; Uh G; Morgenstern R
    J Neural Transm (Vienna); 2001; 108(2):141-51. PubMed ID: 11314769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
    Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
    Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.